Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 344,000 | 1,862,000 | 5,084,000 | 3,364,000 | 4,749,000 |
| Cost of Goods | 731,000 | 792,000 | 1,918,000 | 1,100,000 | 1,381,000 |
| Gross Profit | -387,000 | 1,070,000 | 3,166,000 | 2,264,000 | 3,368,000 |
| Operating Expenses | 1,480,000 | 1,436,000 | 1,586,000 | 1,098,000 | 921,000 |
| Operating Income | -1,867,000 | -366,000 | 1,580,000 | 1,166,000 | 2,447,000 |
| Other Income | 118,000 | 61,000 | 75,000 | 51,000 | 27,000 |
| Pre-tax Income | -1,749,000 | -305,000 | 1,655,000 | 1,217,000 | 2,474,000 |
| Income Tax | -369,000 | -384,000 | 190,000 | 174,000 | 277,000 |
| Net Income Continuous | -1,380,000 | 79,000 | 1,465,000 | 1,043,000 | 2,197,000 |
| Net Income | $-1,380,000 | $79,000 | $1,465,000 | $1,043,000 | $2,197,000 |
| EPS Basic Total Ops | -3.62 | 0.20 | 3.95 | 2.67 | 5.55 |
| EPS Basic Continuous Ops | -3.62 | 0.20 | 3.90 | 2.67 | 5.55 |
| EPS Diluted Total Ops | -3.62 | 0.19 | 3.77 | 2.53 | 5.24 |
| EPS Diluted Continuous Ops | -3.62 | 0.20 | 3.74 | 2.53 | 5.24 |
| EBITDA(a) | $-1,787,000 | $-305,000 | $1,656,000 | $1,285,000 | $2,534,000 |